Shanghai Juncell Therapeutics
Clinical trials sponsored by Shanghai Juncell Therapeutics, explained in plain language.
-
First human test: can your own immune cells fight advanced cancer?
Disease control CompletedThis early-stage study tested the safety of a personalized immunotherapy for people with advanced solid tumors. Doctors collected immune cells from patients' tumors, grew more of them in a lab, and then reinfused them back into 43 participants to see if they could fight the cance…
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists reprogram Patients' own immune cells to fight advanced gynecologic cancers
Disease control CompletedThis early-phase study tested a new treatment called GC203 TIL for advanced gynecologic cancers. Doctors took immune cells from patients' tumors, genetically modified them to be more powerful, grew large quantities, and infused them back into 26 patients who had run out of standa…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists fight melanoma with Patient's own supercharged immune cells
Disease control CompletedThis study tested a personalized cell therapy for people with advanced melanoma that had stopped responding to standard treatments. Doctors took immune cells from a patient's own tumor, grew large numbers of them in a lab, and then infused them back into the patient. The main goa…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC